HORIZON-EIC-2024-ACCELERATOROPEN-01
HORIZON-EIC-2024-ACCELERATOROPEN-01
Programme: Horizon Europe
101 projects · €247,719,132 total EU contribution (project-level) · 105 participating organizations · 20 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€247,719,132
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (17)
- France (12)
- IL (10)
- Spain (9)
- Netherlands (9)
- SE (9)
- FI (6)
- BE (5)
- Italy (5)
- UK (5)
- DK (4)
- LT (4)
- IE (2)
- PL (2)
- AT (1)
- EE (1)
- EL (1)
- HR (1)
- LU (1)
- PT (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- ABSOLUT SENSING1 projects · FR
- AINDO1 projects · IT
- AIRFORESTRY1 projects · SE
- AISPECO, UAB1 projects · LT
- ALTRATECH LIMITED1 projects · IE
- AlzeCure Pharma1 projects · SE
- APMONIA THERAPEUTICS1 projects · FR
- ARGO SEMICONDUCTORS SOCIETE ANONYME1 projects · EL
- Astrape Networks1 projects · NL
- ATMOS SPACE CARGO GMBH1 projects · DE
- AURA AERO1 projects · FR
- Barocal Ltd1 projects · UK
Projects
Page 8 of 11
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
INNOVATIVE SOLUTION OF ELECTRO-FOCUS EYEGLASSES I-SEE · 101188752 | HORIZON | €2,499,999 | €0 | Details |
Next generation gene writing platform to cure genetic and oncological diseases FiCAT · 101188324 | HORIZON | €2,496,375 | €0 | Details |
Next-Gen Wireless Chip and Antenna Tech for Wi-Fi 8 SWIFT · 101188842 | HORIZON | €2,490,416 | €0 | Details |
Final development and commercial preparation of Phactory™, a universal platform technology to enable scalable phagebased drug development and production Phactory · 101218038 | HORIZON | €2,499,999 | €0 | Details |
Clinical validation of an antibiotic-resistant bacteria global vaccine platform through the first vaccine against Klebsiella pneumoniae K-VAX · 101189068 | HORIZON | €2,494,749 | €0 | Details |
ReMLP: Recycling Multi-Layer Plastic ReMLP · 101188563 | HORIZON | €2,297,532 | €0 | Details |
Novel peptide-based therapeutics for reprogramming the tumour stroma extracellular matrix using molecular modelling and computational engineering ACT-MATRIX · 101188310 | HORIZON | €2,434,790 | €0 | Details |
SPACTORY, revolutionising pharmaceutical development and manufacturing through microgravity SPACTORY · 101189238 | HORIZON | €2,184,053 | €0 | Details |
Accessible MRI AMRI · 101189123 | HORIZON | €2,499,999 | €0 | Details |
Enabling on-site mechanical analysis of drill cores for sustainable and efficient mining LASO-LIBS · 101218479 | HORIZON | €2,495,500 | €0 | Details |